Source: Journal of Cellular and Molecular Medicine. Unidades: FMRP, FORP
Subjects: TROMBOEMBOLISMO, METALOPROTEINASES, HIPERTENSÃO PULMONAR, MIOCARDIOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETO-NEVES, Evandro M. et al. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism. Journal of Cellular and Molecular Medicine, v. 17, n. 12, p. 1588-1597, 2013Tradução . . Disponível em: https://doi.org/10.1111/jcmm.12163. Acesso em: 31 out. 2024.APA
Neto-Neves, E. M., Sousa-Santos, O., Ferraz, K. C., Rizzi, E., Ceron, C. S., Romano, M. M. D., et al. (2013). Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism. Journal of Cellular and Molecular Medicine, 17( 12), 1588-1597. doi:10.1111/jcmm.12163NLM
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Rizzi E, Ceron CS, Romano MMD, Gali LG, Maciel BC, Schulz R, Gerlach RF, Tanus-Santos JE. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism [Internet]. Journal of Cellular and Molecular Medicine. 2013 ; 17( 12): 1588-1597.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/jcmm.12163Vancouver
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Rizzi E, Ceron CS, Romano MMD, Gali LG, Maciel BC, Schulz R, Gerlach RF, Tanus-Santos JE. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism [Internet]. Journal of Cellular and Molecular Medicine. 2013 ; 17( 12): 1588-1597.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/jcmm.12163
